Skip to content
Term: --%

Receipts / Metric 7 of 11 / Healthcare

Receipt: Healthcare Costs (Prescription Drugs)

From the Year 1 check-in published , against the scorecard locked in November 2024. The grade is editorial judgement; the figures carry their own dates.

Metric 7 of 11 / Healthcare

Healthcare Costs (Prescription Drugs)

Our grade
F (editorial judgement)
Promise
Cut prescription drug out-of-pocket costs by 20%.
Baseline
$100 / month average out-of-pocket, as of 2024 (agreed baseline)
Target
$80 / month (-20%), by end of term
Recorded at Year 1
No measurable change to typical patient out-of-pocket costs
Evidence as of
October 2025 (Forbes analysis)
Our verdict
Signed an executive order, held the photo op, drug prices unchanged. The pharma lobby wrote him a thank you card.
Check-in
Year 1, published ; archive entry recorded

The grade and verdict are editorial judgement against the target locked in November 2024. Figures are as recorded in the Year 1 check-in, with the dates shown.

Sources and limits

Sources accompanying the Year 1 archive

Method and limits

Agreed measure: Track changes in pricing data from healthcare expenditure reports.

Year 1 method note: No dollar figure was recorded against the $100 baseline. The grade rests on analysis showing no measurable change for typical patients.

Archive note (Year 1): Recorded on 15/11/2026 from the Year 1 assessment published on 24/05/2026. Grades, figures and verdicts are as published that day, except two DOGE figures corrected on 15/11/2026: the verified share of DOGE's claim (published as about 30%) and the source of the $135 billion estimate (published as a CBS analysis). Source lists are as shown on the site on 15/11/2026, including links corrected or added after publication.

The locked register entry · The Year 1 check-in in full · Check-ins (JSON)

Dated corrections: Later evidence and method corrections to this archived assessment.

Download PNG

Receipt link: trumpscorecard.app/receipts/drug-prices